Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/21/2012CA2442204C Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index
02/21/2012CA2436323C Process for preparing clopidogrel
02/21/2012CA2433244C Injectable microdispersions for medical applications
02/21/2012CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein
02/21/2012CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
02/21/2012CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
02/21/2012CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
02/21/2012CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
02/21/2012CA2328074C Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
02/21/2012CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
02/21/2012CA2296841C Tropoelastin derivatives
02/21/2012CA2287800C Compound containing hydroxypropylcellulose, hydroxypropylmethylcellulose, and/or ethylcellulose as disintegrating agents, and production process
02/21/2012CA2264592C Bioconjugates and delivery of bioactive agents
02/21/2012CA2248800C Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
02/21/2012CA2158936C Compositions and methods for utilizing conditionally lethal genes
02/20/2012DE202007019381U1 Manipulationssichere Dosierungsform The tamper-resistant dosage form
02/16/2012WO2012021830A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
02/16/2012WO2012021829A1 Methods of treating bacterial infections
02/16/2012WO2012021819A1 Optimized niacin compositions in pharmaceutical products
02/16/2012WO2012021818A2 Ggf2 and methods of use
02/16/2012WO2012021800A2 Caspase inhibitors as therapeutics for neural and organ injury and imaging
02/16/2012WO2012021791A2 Aqueous formulation with improved stability
02/16/2012WO2012021788A2 Dipeptide calpain inhibitors
02/16/2012WO2012021778A2 Methods for blocking cell proliferation and treating diseases and conditions responsive to cell growth inhibition
02/16/2012WO2012021754A2 Bismuth-thiols as antiseptics for agricultural, industrial and other uses
02/16/2012WO2012021712A1 Tetracycline analogs
02/16/2012WO2012021704A1 Hepatitis c virus inhibitors
02/16/2012WO2012021696A1 Heteroaryls and uses thereof
02/16/2012WO2012021692A1 Curcumin analogs and methods of use thereof
02/16/2012WO2012021647A2 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/16/2012WO2012021629A2 Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
02/16/2012WO2012021615A1 Heteroaryls and uses thereof
02/16/2012WO2012021611A1 Heteroaryls and uses thereof
02/16/2012WO2012021591A1 Hepatitis c virus inhibitors
02/16/2012WO2012021580A1 Quinolyl amines as kinase inhibitors
02/16/2012WO2012021558A1 Methods and compositions for preventing a condition
02/16/2012WO2012021554A1 Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
02/16/2012WO2012021486A2 Acylsulfonamides and processes for producing the same
02/16/2012WO2012021480A1 Combination
02/16/2012WO2012021455A1 Cyclic boronic acid ester derivatives and therapeutic uses thereof
02/16/2012WO2012021409A2 Anthraquinone Analogs
02/16/2012WO2012021392A1 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin
02/16/2012WO2012021382A1 Positive allosteric modulators of mglur2
02/16/2012WO2012021291A2 Methods of treating obstructive lung diseases using bitter tastants
02/16/2012WO2012021287A2 Methods for the treatment and prevention of metabolic disorders
02/16/2012WO2012021172A1 Lipid supplements for maintaining health and the treatment of acute and chronic disorders
02/16/2012WO2012021165A2 Methods and compositions for treating disorders associated with hyperactive immune system
02/16/2012WO2012021144A1 Oligooxopiperazines and methods of making and using them
02/16/2012WO2012021141A1 Antisense antiviral compounds and methods for treating a filovirus infection
02/16/2012WO2012021133A1 Synthetic bile acid compositions and methods
02/16/2012WO2012021107A2 A liposomal formulation for ocular drug delivery
02/16/2012WO2012021068A1 Composition for treating hyperlipidemia
02/16/2012WO2012020989A2 Pharmaceutical or cosmetic composition containing nicotinic acid adenine dinucleotide phosphate or derivative thereof
02/16/2012WO2012020966A2 Theanine derivative, preparation method thereof, and use thereof for alleviating acne
02/16/2012WO2012020892A1 Rhus verniciflua stokes extract having increased content of active flavonoid compound and method for preparing same
02/16/2012WO2012020848A1 Heterocyclic compound and use thereof
02/16/2012WO2012020840A1 Composition for improving skin quality
02/16/2012WO2012020839A1 Pharmaceutical composition for cancer therapy
02/16/2012WO2012020836A1 Therapeutic agent for hepatitis c containing rrm2 antagonist as active ingredient
02/16/2012WO2012020821A1 Prophylactic or therapeutic agent for non-alcoholic steatohepatitis
02/16/2012WO2012020820A1 Heteroaryl-pyrazole derivative
02/16/2012WO2012020813A1 Fused-ring pyrrolidine derivative
02/16/2012WO2012020795A1 Nucleic acid/polysaccharide complex
02/16/2012WO2012020787A1 Malignant lymphoma therapeutic agent
02/16/2012WO2012020786A1 Pharmaceutical composition
02/16/2012WO2012020785A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
02/16/2012WO2012020780A1 Heterocyclic compound and use thereof
02/16/2012WO2012020767A1 Pyrroloquinoline quinone gel
02/16/2012WO2012020762A1 Hetero ring compound
02/16/2012WO2012020749A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012WO2012020742A1 Novel heterocyclic derivatives and pharmaceutical composition containing same
02/16/2012WO2012020738A1 Heterocyclic compound and use thereof
02/16/2012WO2012020726A1 Inhibitor of casein kinase 1δ and casein kinase 1ε
02/16/2012WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism
02/16/2012WO2012020724A1 Process for preparing aminoadamantyl carbamate derivatives
02/16/2012WO2012020567A1 Acyl piperazine derivatives as ttx-s blockers
02/16/2012WO2012020421A1 A novel process for preparation of bosentan
02/16/2012WO2012020389A1 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof
02/16/2012WO2012020377A1 Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation
02/16/2012WO2012020376A1 Peg for the treatment of functional abdominal pains
02/16/2012WO2012020368A1 Olmesartan formulations
02/16/2012WO2012020357A1 Acetamide compounds, their process and pharmaceutical application
02/16/2012WO2012020272A2 New salts, polymorphs and solvates of a pharmaceutical active ingredient
02/16/2012WO2012020270A1 Use of radiprodil in attention deficit hyperactivity disorder
02/16/2012WO2012020258A1 New use of milbemycin derivatives
02/16/2012WO2012020235A1 Treatment
02/16/2012WO2012020227A1 Tricyclic compounds for use as kinase inhibitors
02/16/2012WO2012020217A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
02/16/2012WO2012020215A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
02/16/2012WO2012020170A1 Novel 6,7-disubstituted-isoquinoline derivatives and their use
02/16/2012WO2012020134A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012WO2012020133A1 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012WO2012020130A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012WO2012020097A2 Use of binders for manufacturing storage stable formulations
02/16/2012WO2012020094A1 Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases
02/16/2012WO2012020040A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions
02/16/2012WO2012020037A1 Heterocyclic antiviral compounds
02/16/2012WO2012020036A1 Hepatitis c virus inhibitors
02/16/2012WO2012020035A1 New azacyclic compounds
1 ... 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 ... 7860